TY - JOUR
T1 - Effect of hyperbaric oxygenation on intervertebral disc degeneration
T2 - An in vivo study with sprague-dawley rats
AU - Wang, I. Chun
AU - Liu, Hsien Tao
AU - Yu, Chung Ming
AU - Whu, Shu Wen
AU - Lin, Song Shu
AU - Su, Chun I.
AU - Chen, Chih Hwa
AU - Chen, Wen Jer
PY - 2013/2/1
Y1 - 2013/2/1
N2 - STUDY DESIGN.: An in vivo study was conducted to test the effect of hyperbaric oxygenation (HBO) on intervertebral disc degeneration in Sprague-Dawley rats. OBJECTIVE.: To observe the changes in intervertebral disc height and levels of glycosaminoglycan, collagen, interleukin-1β (IL-1β), prostaglandin E2 (PGE2), and inducible nitric oxide synthase (iNOS) in degenerated intervertebral discs after HBO therapy. SUMMARY OF BACKGROUND DATA.: Although the involvement of IL-1β, PGE-2, NO, and low O2 concentration has been demonstrated in intervertebral disc degeneration, the actual mechanism is not clear. It has been reported that HBO influences changes in IL-1β, PGE-2, NO, and O2 concentration. Previously, a study demonstrated an in vitro positive effect of HBO on the human nucleus pulposus. Thus, an in vivo study in animals was necessary. METHODS.: Twelve Sprague-Dawley rats were each injected with chondroitinase ABC in 2 proximal intervertebral discs of the tail. After treating with 100% oxygen at 2.5 atmospheres 2 hours per days for 10 days, the change in disc height was determined by radiography. The amounts of PGE-2, iNOS, glycosaminoglycan, and total collagen in the intervertebral disc were quantified by enzyme-linked immunosorbent assay. Tissue morphology and the distribution of glycosaminoglycan, IL-1β, and iNOS in the intervertebral disc were assessed by histology and immunohistochemistry. The area of IL-1β in the intervertebral discs was quantified using image analysis software. RESULTS.: HBO therapy stopped the decrease in intervertebral disc height, caused an increase in the amount of glycosaminoglycan, and inhibited IL-1β, PGE-2, and iNOS production. CONCLUSION.: HBO provides a potential treatment modality for intervertebral disc degeneration.
AB - STUDY DESIGN.: An in vivo study was conducted to test the effect of hyperbaric oxygenation (HBO) on intervertebral disc degeneration in Sprague-Dawley rats. OBJECTIVE.: To observe the changes in intervertebral disc height and levels of glycosaminoglycan, collagen, interleukin-1β (IL-1β), prostaglandin E2 (PGE2), and inducible nitric oxide synthase (iNOS) in degenerated intervertebral discs after HBO therapy. SUMMARY OF BACKGROUND DATA.: Although the involvement of IL-1β, PGE-2, NO, and low O2 concentration has been demonstrated in intervertebral disc degeneration, the actual mechanism is not clear. It has been reported that HBO influences changes in IL-1β, PGE-2, NO, and O2 concentration. Previously, a study demonstrated an in vitro positive effect of HBO on the human nucleus pulposus. Thus, an in vivo study in animals was necessary. METHODS.: Twelve Sprague-Dawley rats were each injected with chondroitinase ABC in 2 proximal intervertebral discs of the tail. After treating with 100% oxygen at 2.5 atmospheres 2 hours per days for 10 days, the change in disc height was determined by radiography. The amounts of PGE-2, iNOS, glycosaminoglycan, and total collagen in the intervertebral disc were quantified by enzyme-linked immunosorbent assay. Tissue morphology and the distribution of glycosaminoglycan, IL-1β, and iNOS in the intervertebral disc were assessed by histology and immunohistochemistry. The area of IL-1β in the intervertebral discs was quantified using image analysis software. RESULTS.: HBO therapy stopped the decrease in intervertebral disc height, caused an increase in the amount of glycosaminoglycan, and inhibited IL-1β, PGE-2, and iNOS production. CONCLUSION.: HBO provides a potential treatment modality for intervertebral disc degeneration.
KW - Sprague-Dawley rat model
KW - hyperbaric oxygenation
KW - in vivo
KW - intervertebral disc degeneration
UR - http://www.scopus.com/inward/record.url?scp=84873406630&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84873406630&partnerID=8YFLogxK
U2 - 10.1097/BRS.0b013e31827bf6bf
DO - 10.1097/BRS.0b013e31827bf6bf
M3 - Article
C2 - 23138406
AN - SCOPUS:84873406630
SN - 0362-2436
VL - 38
SP - E137-E142
JO - Spine
JF - Spine
IS - 3
ER -